Innovo Research has appointed Halley Losekamp as senior vice president of corporate strategy and partnerships.

Losekamp, a clinical research and healthcare industry veteran, joins the company after serving in a similar capacity at BEKHealth based in New York, according to a news release.
 
“We couldn’t be happier to have Halley join the Innovo Research team,” said Jeff James, CEO of Innovo Research, in the release. “We’ve proven that our value-based clinical research structure works well for our site partners and study sponsors. Now was the time to find the right person to share our strategy with more organizations looking to change the way that clinical research is viewed and implemented within healthcare systems. We were impressed with Halley’s experience and capabilities and have no doubt that she will positively impact the future of Innovo Research.”
 
In her new role, Losekamp will be responsible for a wide range of activities, including:

• designing and executing growth strategies responsive to partner site interests, strategic priorities, and population health targets;
• establishing a cohesive go-to-market strategy and ensure its alignment with the company's overall strategic plan;
• and spearheading revenue growth through the acquisition of new studies from pharmaceutical sponsors, Contract Research Organizations (CROs), and strategic partners.

“Innovo Research is an agile and dynamic organization that is truly reshaping the clinical research landscape within the healthcare industry,” Losekamp stated in the release. “Showing how clinical research as a care option for patients and moving it into the community is something that I look forward to doing. This movement will simultaneously and safely increase the speed to market for important therapies, drive down healthcare costs and create greater value for patients and providers.”